Patent details

Basic Information

Publication number:

EP1325138

PCT Application Number:

PCT/US/2001/042655

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP019840065

PCT Publication Number:

WO/2002/064799

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

OPTIMIZED MESSENGER RNA

French Title of Invention:

ARN MESSAGER OPTIMISE

German Title of Invention:

OPTIMIERTE BOTEN-RNA (MRNA)

SPC Number:

Dates

Filing date:

11/10/2001

Grant date:

17/07/2013

EP Publication Date:

17/07/2013

PCT Publication Date:

22/08/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

09/07/2003

EP B1 Publication Date:

17/07/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/10/2016

Expiration date:

11/10/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/10/2001

 

 

Name:

Shire Human Genetic Therapies Inc.

Address:

300 Shire Way, Lexington MA 02421, United States (US)

Inventor

1

Name:

MILLER Allan M.

Address:

United States (US)

2

Name:

TRECO Douglas S.

Address:

United States (US)

3

Name:

SELDON Richard F.

Address:

United States (US)

Priority

Priority Number:

686497

Priority Date:

11/10/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

C12N 15/67;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

27/10/2015

Last Annual Fee Paid Number:

15

Last Annual Fee Paid Amount:

213 Euro

Payer:

OFFICE FREYLINGER S.A.

Filing date	Document type	Number of pages